Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03024437 |
Title | Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma |
Recruitment | Suspended |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Roberto Pili |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |